article Open AccessTop 1% cited
Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005
Annals of Oncology · 2005 · Vol. 16(10) · pp. 1569–1583
Aron Goldhirsch✉(International Breast Cancer Study Group)John H. Glick(University of Pennsylvania)Richard D. Gelber(Harvard University)Alan S. Coates(University of Sydney)Beat Thürlimann(Kantonsspital St. Gallen)Hans-Joerg Senn
Breast Cancer Treatment StudiesEstrogen and related hormone effectsBreast Lesions and CarcinomasMedicineEndocrine systemOncologyBreast cancerChemotherapyDiseaseInternal medicineLymph nodeCancerHormone
MeSH terms
Breast NeoplasmsCombined Modality TherapyFemaleHumansLymphatic MetastasisQuality of LifeRandomized Controlled Trials as TopicPremenopauseRisk AssessmentRadiotherapy, AdjuvantAntineoplastic Agents, HormonalGene Expression Profiling
Citations
1,128
FWCI
69.93
field-weighted impact
References
169
Percentile
100%
vs. same field & year
Citations per year
Cited by
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Clinical Chemistry · 2008 · 1,130 citations
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
Annals of Oncology · 2009 · 1,367 citations
An overview of prognostic factors for long-term survivors of breast cancer
Breast Cancer Research and Treatment · 2007 · 512 citations
Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials
Radiotherapy and Oncology · 2007 · 440 citations
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer
JNCI Journal of the National Cancer Institute · 2006 · 1,223 citations
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
Annals of Oncology · 2007 · 939 citations
References
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
Journal of Clinical Oncology · 1999 · 2,057 citations
Prospective identification of tumorigenic breast cancer cells
Proceedings of the National Academy of Sciences · 2003 · 10,327 citations
Self-renewal and solid tumor stem cells
Oncogene · 2004 · 916 citations
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
New England Journal of Medicine · 2004 · 6,318 citations
Cancer incidence and mortality in Europe, 2004
Annals of Oncology · 2005 · 1,211 citations
Mechanisms of Tamoxifen Resistance: Increased Estrogen Receptor-HER2/neu Cross-Talk in ER/HER2-Positive Breast Cancer
JNCI Journal of the National Cancer Institute · 2004 · 1,165 citations
Repeated observation of breast tumor subtypes in independent gene expression data sets
Proceedings of the National Academy of Sciences · 2003 · 5,398 citations
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
New England Journal of Medicine · 2002 · 6,503 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.